[8] compared rates of achieving ATP II LDL-C goals in 3916 hypercholesterolemic patients on atorvastatin, simvastatin, lovastatin, pravastatin (Pravachol; Bristol-Myers Squibb, New York ...

So much interest was placed on the results that a preprint of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE-IT) study results was available from the New England Journal ...

All had recent myocardial infarction or high-risk unstable angina and were randomized in a 1:1 ratio to intensive therapy with atorvastatin (80 mg daily) or moderate therapy with pravastatin (40 ...